Clinical Trial Update: Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating eslicarbazepine acetate as add-on therapy for partial seizures in elderly patients, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2014-07-18